Literature DB >> 33932709

Mast cell tryptases in allergic inflammation and immediate hypersensitivity.

Jonathan J Lyons1, Tangsheng Yi2.   

Abstract

Dysregulated mast cell-mediated inflammation and/or activation have been linked to a number of human diseases, including asthma, anaphylaxis, chronic spontaneous urticaria, and mast cell activation syndromes. As a major mast cell granule protein, tryptase is a biomarker commonly used in clinical practice to diagnose mast cell-associated disorders and -mediated reactions, but its mechanistic roles in disease pathogenesis remains incompletely understood. Here, we summarize recent advances in the understanding of human tryptase genetics and the effects that different genetic composition may have on the quaternary structure of tetrameric mature tryptases. We also discuss how these differences may impact clinical phenotypes including allergic inflammation, immediate hypersensitivity, and others seen in patients with mast cell-associated disorders. With the increased application of next-generation sequencing, we foresee that human genetic approaches will be a major focus of understanding human tryptase functions in various human mast cell disorders and in new therapeutic development.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33932709     DOI: 10.1016/j.coi.2021.04.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  5 in total

1.  Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans.

Authors:  Sarah C Glover; Alexander Carlyle; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-12-09       Impact factor: 6.347

Review 2.  Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.

Authors:  Sarah C Glover; Melody C Carter; Peter Korošec; Patrizia Bonadonna; Lawrence B Schwartz; Joshua D Milner; George H Caughey; Dean D Metcalfe; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-08-13       Impact factor: 6.248

3.  Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells.

Authors:  Chuda Rujitharanawong; Sunisa Yoodee; Kanyarat Sueksakit; Paleerath Peerapen; Papapit Tuchinda; Kanokvalai Kulthanan; Visith Thongboonkerd
Journal:  Cell Tissue Res       Date:  2022-09-20       Impact factor: 4.051

4.  A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases.

Authors:  Youssouf Sereme; Moïse Michel; Soraya Mezouar; Cheick Oumar Guindo; Lanceï Kaba; Ghiles Grine; Thibault Mura; Jean-Louis Mège; Tu Anh Tran; Pierre Corbeau; Anne Filleron; Joana Vitte
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

Review 5.  Challenges in severe asthma: Do we need new drugs or new biomarkers?

Authors:  Adil Adatia; Harissios Vliagoftis
Journal:  Front Med (Lausanne)       Date:  2022-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.